Hemostatic agents
Topical hemostatic agents and membrane adhesives are used as an option to conventional surgical procedures to control bleeding from surgical sites, and are especially useful for diffuse bleeding, bleeding associated with delicate structures, and bleeding in patients with hemostatic anomalies.
Market Insights
According to a Market research analysis, CAGR is expected to be 6.35% between 2021- 2028 period. There are various factors that constitute growth. One of the main reasons being an increase in the number of surgical procedures.
Factors boosting the growth
- Surgical operations increase in number
- Regulatory approval rise
- Increase in sports-related injuries and other ailments
- Need for blood loss management for patients during surgeries
Market Size and Scope
The hemostats market is segmented on the premise of product type, formulation, application, indication, and end-user
By Product type
- Thrombin based,
- Combination,
- Oxidized regenerated cellulose-based,
- Gelatin based and
- Collagen-based hemostat.
By Formulation
- Matrix & gel hemostats,
- Sheet & pad hemostats,
- Sponge hemostats and
- Powder hemostats.
By Application
- orthopedic, general surgery,
- neurological surgery,
- cardiovascular surgery,
- reconstructive surgery and
- gynecological surgery
By Indication
- Wound Closure
- Surgery
By End-User
- hospitals,
- clinics,
- ambulatory centers,
- community healthcare etc
Market data by region
Asia-Pacific dominates the hemostats market due to the increase in the huge amount of operations conducted in the area as well as the expansion of technologically superior goods for attaining blood control during trauma-related methods in this area. Other hugely marketed countries/regions include the USA, Europe, Africa.
Competitors Involved
- Baxter, Teleflex,
- B. Braun Melsungen AG,
- 3-D Matrix Medical Technology,
- RESORBA Medical GmbH,
- Anika Therapeutics, Inc.,
- Stryker
- Medtronics
- BioCer Gmbh
Hemostat powder market
Additionally, The global Hemostat Powder market is valued at USD 345.5 million in 2019. The market size will reach USD 508 million by the end of 2026, growing at a CAGR of 5.6% during 2021-2026. This information could be crucial for dealers and distributors.
 Top Key Players in Hemostat Powder
- Johnson and Johnson
- C. R. Bard
- Pfizer
- CSL Behring
- Gelita Medical
- Ferrosan Medical Devices
- Baxter
- Celox
- Equimedical
- Medira
- Biocer
Haemocer – Enhancer of natural blood clot process
Hemostatic powder like HaemoCer Plus is used when the normal blood clotting process needs a little push to fasten the blood clotting.
Plant-based HaemoCer Plus is an absorbable polysaccharide hemostat. They are prepared by a process known as PURE. It has no animal or human components present in it. HaemoCer Plus works by enhancing the natural clotting process without directly involving in any chemical reaction.
BioCer, a medical device company based in Bayreuth, Germany. They specialize in the development and production of innovative medical biomaterial products without animal or human components.
Morulaa Healthtech Pvt. Ltd is the licensed importer of BioCer products.
HaemoCer Plus can be considered a staple in the wound healing product line. The distributors in India mainly dealing with wound care and surgical products may add this product to their inventory.
A comparison study between HaemoCer Plus and its competitors showed that HaemoCer Plus showed higher blood absorption compared to surgical products like hemostatic agents of Arista, Perclot, and Surgicel.
Conclusion
HaemoCer Plus is a CE, CDSCO approved medical device. In this article, The global market data of Hemostats is shown along with the Morulaa licensed BioCer product is discussed. This Morulaa imported medical device is easy to use, safe and effective that can be used in different kinds of surgeries.
This article is intended to give product information on HaemoCer Plus Haemostatic powder India. To know more about the product details, brochure and information about other medical devices please visit products.morulaa.com.
Morulaa is a turnkey solution provider with an in-house Regulatory Consultancy team to conduct registrations of medical devices. Morulaa provides high-quality and professional services for Regulatory Consultancy and we aim at developing long-term relationships for the Indian Market.
